EU access to oncology medicines lags behind in the Netherlands
In a report, findings suggested that cancer patients in the Netherlands will face longer waits to access new oncology medicines.
In a report, findings suggested that cancer patients in the Netherlands will face longer waits to access new oncology medicines.
What's Your Reaction?
